Tuesday, January 26, 2021

Very Brief Blog: Talis Biomedical Files for IPO; 2nd Molecular Microbiology Startup in a Week

Last week, I had a Brief Blog flagging that LUCIRA had filed for a $115M IPO based in part on its EUA for an all-in-one 30-minute COVID molecular test - here.  (I included a link to the 285-page S-1 SEC document).

A few days later, here is another one.  TALIS Biomedical has also filed for an IPO [TBD insert valuation here].   

  • See subscription coverage at SF Business Journal here.
  • See open access coverage at Genomeweb here.
  • See their 275-page S-1 SEC IPO document here.

Per Genomeweb, the firm is among a group of six diagnostics companies together awarded $250M in 2020 related to the COVID pandemic. 

Talis Biomedical Platform and Cartridge for COVID